Results 201 to 206 of about 17,592 (206)

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

Breast Cancer Research and Treatment, 2019
Hope S Rugo, R S Finn, V Dieras
exaly  

Phase I study of palbociclib, a cyclin‐dependent kinase 4/6 inhibitor, in Japanese patients

Cancer Science, 2016
Kenji Tamura, Hirofumi Mukai, Yoichi Naito   +2 more
exaly  

A theoretical study of the structure and protonation of Palbociclib (PD 0332991)

Journal of Molecular Structure, 2014
Ibon Alkorta, JOSÉ Elguero
exaly  

Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases

Annals of Oncology, 2018
N C Turner, MIGUEL Martin, A Demichele   +2 more
exaly  

Severe acute radiation-induced enterocolitis after combined palbociclib and palliative radiotherapy treatment

Radiotherapy and Oncology, 2019
Terufumi Kawamoto, Naoto Shikama, Keisuke Sasai   +2 more
exaly  

Palbociclib

Drugs of the Future, 2013
openaire   +1 more source